当前位置:首页 - 行情中心 - 海翔药业(002099) - 财务分析 - 利润表

海翔药业

(002099)

4.46

-0.02  (-0.45%)

今开:4.46最高:4.51成交:2.18万手 市盈:0.00 上证指数:2589.66   -0.20%2018-10-24
昨收:4.48 最低:4.44 换手:0.00%振幅:0.00 深证指数:7532.11  -0.57%10:37:54

集合

竞价

利润表

按照会计年度查询:
报告期2018-09-302018-06-302018-03-312017-12-31
一、营业总收入2,064,094,898.741,365,959,172.78610,754,044.642,308,922,170.29
营业收入2,064,094,898.741,365,959,172.78610,754,044.642,308,922,170.29
二、营业总成本1,505,885,280.531,041,175,885.15550,796,225.351,950,977,271.92
营业成本1,169,655,091.47795,549,320.08355,150,701.211,317,395,106.66
营业税金及附加23,476,466.4515,397,803.67,561,598.827,508,270.21
销售费用23,408,975.1314,946,767.365,332,419.1239,274,842.64
管理费用257,358,345.6214,746,885.3597,692,175.08423,374,490.35
财务费用-49,004,740.52-572,212.7784,704,153.96141,778,261.82
资产减值损失826,203.891,107,321.53355,177.181,646,300.24
三、其他经营收益-265,226.8207,045.7986,998.819,189.52
允许价值变动净收益5,010,265.75,010,265.75,010,265.7-5,010,265.7
投资净收益-9,134,085.52-9,950,410.83-5,810,881.1636,897,265.28
联营、合营企业投资收益-5,899,242.04-4,787,145.13-647,615.46189,814.34
汇兑净收益--------
四、营业利润560,631,047.29323,690,265.9260,605,832.37399,674,606.98
营业外收入1,683,578.671,310,567.3817,678.033,665,249.44
营业外支出2,523,748.9780,401.13305,858.573,475,751.5
非流动资产处置净损失--------
五、利润总额559,790,877.06324,220,432.1760,317,651.83399,864,104.92
所得税76,770,441.5148,367,146.115,549,202.0757,507,433.48
未确认的投资损失--------
六、净利润(百万元)483.02275.8544.77342.22
少数股东损益------139,515.84
归属于母公司股东的净利润483,020,435.55275,853,286.0744,768,449.76342,217,155.6
七、每股收益0.30.170.030.22
基本每股收益--0.170.030.22
稀释每股收益--0.170.030.21
TOP↑